Home | Business News | Browse by Publication | M | M2 Presswire

TIL, VIAP, ORMT, EJPRY, VWDRY, EISFF Have Been Added To Naked Short List Today.

Publication: M2 Presswire
Publication Date: 31-DEC-08
Format: Online
Delivery: Immediate Online Access

Article Excerpt
M2 PRESSWIRE-31 December 2008-BUYINS.NET: TIL, VIAP, ORMT, EJPRY, VWDRY, EISFF Have Been Added To Naked Short List Today(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:31122008

BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list: TransIndia Acquisition Corpor (AMEX: TIL), VIA Pharmaceuticals Inc. (NASDAQ: VIAP), Ormet Corp (OTC: ORMT), East Japan Railway Co. (OTC: EJPRY), Vestas Wind Systems AS (OTC: VWDRY), Eveready Income Fund (OTC: EISFF). For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to www.buyins.net.

TransIndia Acquisition Corpor (AMEX: TIL) does not have significant operations. The company intends to acquire businesses with operations through a merger, capital stock exchange, asset acquisition, or other similar business combination in India. It principally focuses on the acquisition of companies engaged in the drug research and clinical trials, manufacturing of drugs and drug products, medical devices, diagnostic products and services, biofuels, and agricultural biotechnology business. Trans-India Acquisition Corporation was founded in 2006 and is based in Chicago, Illinois. With 14.2 million shares outstanding and 3,100 shares declared short as of October 2008, there is a failure to deliver in shares of TIL. According to quarterly data provided by the SEC, there were still 419,100 shares of TIL that were failing-to-deliver as of March 16, 2007.

VIA Pharmaceuticals Inc. (NASDAQ: VIAP) a development stage biotechnology company, focuses on the research and development of compounds for the treatment cardiovascular diseases. The company is building a pipeline of small-molecule drugs that target inflammation in the blood vessel wall, an underlying cause of atherosclerosis and its complications, including heart attack and stroke. Its principal product, VIA-2291, is...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from M2 Presswire
(ABAX) SqueezeTrigger Price is $15.363. There is $52,893,225.00 That S..., December 31, 2008
(ABFS) SqueezeTrigger Price is $29.384. There is $145,429,020.00 That ..., December 31, 2008
(BLL) SqueezeTrigger Price is $41.623. There is $132,790,050.00 That S..., December 31, 2008
Bulgarian Banks Aggressively Building Deposits, Flouting Economic Melt..., December 31, 2008
Michael Miller from Que Publishing and Jeremy Buck from Diskeeper to b..., December 31, 2008

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.